The Evolving Landscape of Pharmaceutical Litigation in America

The pharmaceutical sector is witnessing a groundswell of legal challenges, with the likes of diabetes medications coming under the legal microscope alongside a range of other treatments. What does this mean for the industry’s future? This transformation in litigation sets new precedents that could alter how companies approach drug development and consumer safety.